Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More
Health insurer stocks are surging after the market close on Monday, following the Centers for Medicare and Medicaid Services' (CMS) finalization of payment policies for 2027.
ClearCostRecovery.com has launched as a free addiction treatment cost transparency resource, offering a first-of-its-kind interactive calculator that allows individuals and families to estimate inpatient rehabilitation costs before making a single phone call to a treatment facility.
Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
As the first quarter of 2026 draws to a close, the S&P 500 is witnessing one of the most dramatic sector performance splits in recent financial history. According to consensus estimates as of March 17, 2026, the Finance sector is projected to report a staggering 19% year-over-year earnings growth,
What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ...
A new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP)—conducted by a Humana Healthcare Research team and Dr. Joseph S. Ross of the Yale School of Medicine—reveals a notable increase in the use of continuous glucose monitors (CGMs) among Medicare Advantage members with type 2 diabetes from 2021 to 2023.
The healthcare investment landscape was irrevocably altered this quarter as UnitedHealth Group (NYSE:UNH) witnessed a historic 20% collapse in its market valuation. The blue-chip titan, long considered the bedrock of the Dow Jones Industrial Average, shocked investors by forecasting its first annual revenue contraction in over 36 years. This
As of March 11, 2026, the Dow Jones Industrial Average is grappling with a heavyweight problem. UnitedHealth Group (NYSE: UNH), long the gold standard of the managed care sector and a primary engine of the index’s growth over the last decade, has transformed into its most significant anchor. With
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a...
HealthMarkets Insurance Agency has announced a Medicare plan comparison service in Jacksonville, FL, giving residents access to multiple top-rated carriers through a single, no-cost consultation with Founder Derek Rogers — making one of retirement's most consequential financial decisions considerably less costly to get wrong.
Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 6.625 percent of the principal amount (the “Junior Subordinated Notes Offering”).
AM Best has assigned a Long-Term Issue Credit Rating of “bbb-” (Good) to the $1 billion, 6.625% fixed rate junior subordinated notes, due 2056, of Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM]. The outlook assigned to this Credit Rating (rating) is stable. All other ratings of Humana and its subsidiaries remain unchanged.
Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the “Junior Subordinated Notes Offering”). The Junior Subordinated Notes Offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions.
Humana Inc. (NYSE: HUM), a leading U.S. healthcare company, today announced new partnerships to improve heart health for eligible Medicare Advantage members through value-based care. Building on Humana’s existing cardiac care partnership with CVAUSA’s Novocardia Care Solutions division, new agreements with Karoo Health, US Heart and Vascular and Chamber Cardio further expand the company’s comprehensive cardiac care program.
